Comparison of inpatient admission rates of patients treated with apixaban vs. warfarin for venous thromboembolism in the emergency department

References

• Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12:464–474.
   PubMed Web of Science ®Google Scholar
• Beckman MG, Hooper WC, Critchley SE, et al. Venous thromboembolism: A public health concern. Am J Prev Med. 2010;30(4 Suppl):S495–S501.
   Google Scholar
• Centers for Disease Control and Prevention. Venous thromboembolism (blood clots). Updated June 22; 2015. [updated 2019 Aug 1; cited 2019 Aug 1]. Available from: https://www.cdc.gov/ncbddd/dvt/data.html
   Google Scholar
• Mahan CE, Borrego ME, Woersching AL, et al. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost. 2012;108:291–302.
   PubMed Web of Science ®Google Scholar
• Deitelzweig SB, Johnson BH, Lin J, et al. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol. 2011;86:217–220.
   PubMed Web of Science ®Google Scholar
• Brahmandam A, Abougergi MS, Ochoa Chaar CI. National trends in hospitalizations for venous thromboembolism. J Vasc Surg Venous Lymphat Disord. 2017;5:621–629.e2.
   PubMedGoogle Scholar
• Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: american College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e419S–e496S.
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Omelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315–352.
   PubMed Web of Science ®Google Scholar
• Deitelzweig S, Guo JD, Hlavacek P, et al. Hospital resource utilization and costs associated with warfarin versus apixaban treatment among patients hospitalized for venous thromboembolism in the United States. Clin Appl Thromb Hemost. 2018;24(9Suppl):261S–268S.
   Google Scholar
• Amin A, Bruno A, Trocio J, et al. Real-world medical cost avoidance when new oral anticoagulants are used versus warfarin for venous thromboembolism in the United States. Clin Appl Thromb Hemost. 2016;22:5–11.
   PubMed Web of Science ®Google Scholar
• Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361:2342–2352.
   PubMed Web of Science ®Google Scholar
• Bauersachs R, Berkowitz SD, Einstein Investigators, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499–2510.
   PubMed Web of Science ®Google Scholar
• Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369:799–808.
   PubMed Web of Science ®Google Scholar
• Buller HR, Decousus H, Hokusai-VTE Investigators, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013;369:1406–1415.
   PubMed Web of Science ®Google Scholar
• Premier Applied Sciences, the Research and Analytics Division of Premier Inc. Charlotte, NC. [updated 2019 Aug 1; cited 2019 Aug 1]. Available from: https://products.premierinc.com/downloads/PremierHealthcareDatabaseWhitepaper.pdf
   Google Scholar
• Liu X, Johnson M, Mardekian J, et al. Apixaban reduces hospitalizations in patients with venous thromboembolism: an analysis of the apixaban for the initial management of pulmonary embolism deep-vein thrombosis as first-line therapy (AMPLIFY) trial. J Am Heart Assoc. 2015;4:e002340.
   PubMed Web of Science ®Google Scholar
• Wolf SJ, Hahn SA, American College of Emergency Physicians Clinical Policies Subcommittee on Thromboembolic Disease, et al. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected acute venous thromboembolic disease. Ann Emerg Med. 2018;71:e59–e109.
   PubMedGoogle Scholar
• Singer AJ, Thode HC Jr, Peacock WF. 4th. Admission rates for emergency department patients with venous thromboembolism and estimation of the proportion of low risk pulmonary embolism patients: a US perspective. Clin Exp Emerg Med. 2016;30:126–131.
   Google Scholar
• Peacock WF, Levy PD, Gonzalez MG, et al. Target-specific oral anticoagulants in the emergency department. J Emerg Med. 2016;50:246–257.
   PubMed Web of Science ®Google Scholar
• Barret TW, Wrenn KD, Slovis CM, et al. An outpatient management protocol for emergency department patients with a newly diagnosed lower extremity deep venous thrombosis. Crit Pathw Cardiol. 2016;15:75–76.
   PubMedGoogle Scholar
• Kabrhel C, Rosovsky R, Baugh C, et al. The creation and implementation of an outpatient pulmonary embolism treatment protocol. Hosp Pract (1995). 2017;45:123–129.
   PubMedGoogle Scholar
• Kelliher S, Hail P, Kevane B, et al. Implementation of an acute DVT ambulatory care pathway in a large urban centre: current challenges and future opportunities. Thromb J. 2019;17:14.
   PubMed Web of Science ®Google Scholar
• Ghazvinian R, Gottsäter A, Elf JL. Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism. J Thromb Thrombolysis. 2018;45:319–324.
   PubMed Web of Science ®Google Scholar
• El Yaaggubi A, Michelet P, Vaïsse B, et al. Evaluation of an “Emergency Thrombosis” care system in a university-hospital department of general emergencies. J Med Vasc. 2019;44:184–193.
   PubMedGoogle Scholar
• Beam DM, Kahler ZP, Kline JA. Immediate discharge and home treatment with rivaroxaban of low-risk venous thromboembolism diagnosed in two U.S. emergency departments: A one-year preplanned analysis. Acad Emerg Med. 2015;22:788–795.
   PubMed Web of Science ®Google Scholar
• Deitelzweig S, Laliberté F, Crivera C, et al. Hospitalizations and other health care resource utilization among patients with deep vein thrombosis treated with rivaroxaban versus low-molecular-weight heparin and warfarin in the outpatient setting. Clin Ther. 2016;38:1803–1816.e3.
   PubMed Web of Science ®Google Scholar